nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—connective tissue—age related macular degeneration	0.136	0.3	CbGeAlD
Amlexanox—S100A13—eye—age related macular degeneration	0.0668	0.148	CbGeAlD
Amlexanox—S100A13—connective tissue—age related macular degeneration	0.0644	0.142	CbGeAlD
Amlexanox—S100A12—connective tissue—age related macular degeneration	0.0635	0.141	CbGeAlD
Amlexanox—FGF1—eye—age related macular degeneration	0.0411	0.091	CbGeAlD
Amlexanox—FGF1—retina—age related macular degeneration	0.0408	0.0902	CbGeAlD
Amlexanox—FGF1—connective tissue—age related macular degeneration	0.0396	0.0877	CbGeAlD
Amlexanox—IL3—Senescence and Autophagy in Cancer—COL10A1—age related macular degeneration	0.0328	0.0598	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.0224	0.0409	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—SQSTM1—age related macular degeneration	0.0145	0.0265	CbGpPWpGaD
Amlexanox—IL3—Signaling by Interleukins—SQSTM1—age related macular degeneration	0.0142	0.0259	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—F13B—age related macular degeneration	0.0123	0.0224	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—SERPING1—age related macular degeneration	0.0116	0.0211	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.0111	0.0202	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—RAD51B—age related macular degeneration	0.01	0.0183	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00992	0.0181	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—SLC16A8—age related macular degeneration	0.00932	0.017	CbGpPWpGaD
Amlexanox—IL3—Differentiation Pathway—VEGFA—age related macular degeneration	0.00867	0.0158	CbGpPWpGaD
Amlexanox—S100A12—MyD88:Mal cascade initiated on plasma membrane—CD36—age related macular degeneration	0.00852	0.0155	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—C9—age related macular degeneration	0.00834	0.0152	CbGpPWpGaD
Amlexanox—S100A12—MyD88:Mal cascade initiated on plasma membrane—TLR4—age related macular degeneration	0.00737	0.0134	CbGpPWpGaD
Amlexanox—S100A12—Activated TLR4 signalling—CD36—age related macular degeneration	0.00736	0.0134	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CFI—age related macular degeneration	0.00723	0.0132	CbGpPWpGaD
Amlexanox—S100A12—MyD88-independent cascade—TLR4—age related macular degeneration	0.00707	0.0129	CbGpPWpGaD
Amlexanox—S100A12—Toll Like Receptor 4 (TLR4) Cascade—CD36—age related macular degeneration	0.00692	0.0126	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CFHR3—age related macular degeneration	0.00672	0.0123	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—SQSTM1—age related macular degeneration	0.00662	0.0121	CbGpPWpGaD
Amlexanox—S100A12—Activated TLR4 signalling—TLR4—age related macular degeneration	0.00636	0.0116	CbGpPWpGaD
Amlexanox—S100A12—Toll-Like Receptors Cascades—CD36—age related macular degeneration	0.00616	0.0112	CbGpPWpGaD
Amlexanox—IL3—Immune System—C9—age related macular degeneration	0.00606	0.0111	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—C2—age related macular degeneration	0.00599	0.0109	CbGpPWpGaD
Amlexanox—S100A12—Toll Like Receptor 4 (TLR4) Cascade—TLR4—age related macular degeneration	0.00598	0.0109	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00537	0.00979	CbGpPWpGaD
Amlexanox—S100A12—Toll-Like Receptors Cascades—TLR4—age related macular degeneration	0.00533	0.00972	CbGpPWpGaD
Amlexanox—IL3—Immune System—CFI—age related macular degeneration	0.00526	0.00959	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—RHO—age related macular degeneration	0.00512	0.00935	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00506	0.00923	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CFH—age related macular degeneration	0.00501	0.00915	CbGpPWpGaD
Amlexanox—IL3—Immune System—CFHR3—age related macular degeneration	0.00489	0.00892	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CFB—age related macular degeneration	0.00486	0.00887	CbGpPWpGaD
Amlexanox—S100A12—Immune System—C9—age related macular degeneration	0.00486	0.00886	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—C9—age related macular degeneration	0.00477	0.0087	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—RHO—age related macular degeneration	0.00465	0.00849	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00455	0.00829	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RDH8—age related macular degeneration	0.00448	0.00818	CbGpPWpGaD
Amlexanox—IL3—Immune System—C2—age related macular degeneration	0.00436	0.00795	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CFI—age related macular degeneration	0.00421	0.00769	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CFI—age related macular degeneration	0.00413	0.00754	CbGpPWpGaD
Amlexanox—FGF1—Differentiation Pathway—VEGFA—age related macular degeneration	0.00397	0.00724	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RPE65—age related macular degeneration	0.00392	0.00715	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CFHR3—age related macular degeneration	0.00392	0.00715	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CFHR3—age related macular degeneration	0.00384	0.00701	CbGpPWpGaD
Amlexanox—IL3—Immune System—CFH—age related macular degeneration	0.00364	0.00665	CbGpPWpGaD
Amlexanox—IL3—Immune System—CFB—age related macular degeneration	0.00353	0.00645	CbGpPWpGaD
Amlexanox—S100A12—Immune System—C2—age related macular degeneration	0.00349	0.00637	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—C2—age related macular degeneration	0.00343	0.00625	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—RHO—age related macular degeneration	0.00328	0.00599	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ABCA4—age related macular degeneration	0.00316	0.00576	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—SQSTM1—age related macular degeneration	0.00298	0.00544	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—RHO—age related macular degeneration	0.00298	0.00544	CbGpPWpGaD
Amlexanox—FGF1—Disease—RDH8—age related macular degeneration	0.00293	0.00535	CbGpPWpGaD
Amlexanox—FGF1—Disease—NMNAT1—age related macular degeneration	0.00293	0.00535	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CFH—age related macular degeneration	0.00292	0.00533	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RDH8—age related macular degeneration	0.00287	0.00524	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00287	0.00524	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CFH—age related macular degeneration	0.00287	0.00523	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—RHO—age related macular degeneration	0.00286	0.00521	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CFB—age related macular degeneration	0.00283	0.00517	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CFB—age related macular degeneration	0.00278	0.00507	CbGpPWpGaD
Amlexanox—FGF1—Immune System—C9—age related macular degeneration	0.00278	0.00507	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—CD36—age related macular degeneration	0.00277	0.00505	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RHO—age related macular degeneration	0.00275	0.00501	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—RHO—age related macular degeneration	0.00272	0.00496	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—RHO—age related macular degeneration	0.0026	0.00473	CbGpPWpGaD
Amlexanox—FGF1—Disease—RPE65—age related macular degeneration	0.00256	0.00468	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00256	0.00466	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—RHO—age related macular degeneration	0.00252	0.00459	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RPE65—age related macular degeneration	0.00251	0.00458	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RDH8—age related macular degeneration	0.0025	0.00456	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—RHO—age related macular degeneration	0.00247	0.00451	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CFI—age related macular degeneration	0.00241	0.00439	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RDH8—age related macular degeneration	0.00238	0.00434	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—RHO—age related macular degeneration	0.00229	0.00417	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CFHR3—age related macular degeneration	0.00224	0.00408	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RDH8—age related macular degeneration	0.0022	0.00402	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RPE65—age related macular degeneration	0.00219	0.00399	CbGpPWpGaD
Amlexanox—IL3—Immune System—SQSTM1—age related macular degeneration	0.00216	0.00395	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RPE65—age related macular degeneration	0.00208	0.0038	CbGpPWpGaD
Amlexanox—FGF1—Disease—ABCA4—age related macular degeneration	0.00207	0.00377	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RDH8—age related macular degeneration	0.00205	0.00375	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ABCA4—age related macular degeneration	0.00202	0.00369	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CD36—age related macular degeneration	0.002	0.00364	CbGpPWpGaD
Amlexanox—FGF1—Immune System—C2—age related macular degeneration	0.002	0.00364	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RPE65—age related macular degeneration	0.00193	0.00351	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—C3—age related macular degeneration	0.00189	0.00345	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CRP—age related macular degeneration	0.0018	0.00328	CbGpPWpGaD
Amlexanox—FGF1—Disease—RHO—age related macular degeneration	0.0018	0.00328	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RPE65—age related macular degeneration	0.0018	0.00328	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ABCA4—age related macular degeneration	0.00176	0.00322	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RHO—age related macular degeneration	0.00176	0.00321	CbGpPWpGaD
Amlexanox—S100A12—Immune System—SQSTM1—age related macular degeneration	0.00173	0.00316	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—TLR4—age related macular degeneration	0.00173	0.00315	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ABCA4—age related macular degeneration	0.00168	0.00306	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CFH—age related macular degeneration	0.00167	0.00304	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—C3—age related macular degeneration	0.00166	0.00302	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CFB—age related macular degeneration	0.00162	0.00295	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ABCA4—age related macular degeneration	0.00155	0.00283	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFBR1—age related macular degeneration	0.00154	0.00282	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RHO—age related macular degeneration	0.00153	0.0028	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—C3—age related macular degeneration	0.0015	0.00274	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RHO—age related macular degeneration	0.00146	0.00266	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD36—age related macular degeneration	0.00145	0.00265	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ABCA4—age related macular degeneration	0.00145	0.00264	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SQSTM1—age related macular degeneration	0.0014	0.00255	CbGpPWpGaD
Amlexanox—IL3—Immune System—C3—age related macular degeneration	0.00137	0.00251	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RHO—age related macular degeneration	0.00135	0.00246	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—VEGFA—age related macular degeneration	0.00132	0.0024	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00132	0.0024	CbGpPWpGaD
Amlexanox—IL3—Immune System—CRP—age related macular degeneration	0.00131	0.00239	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RHO—age related macular degeneration	0.00126	0.0023	CbGpPWpGaD
Amlexanox—IL3—Immune System—TLR4—age related macular degeneration	0.00125	0.00229	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CCL2—age related macular degeneration	0.00118	0.00215	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD36—age related macular degeneration	0.00116	0.00212	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD36—age related macular degeneration	0.00114	0.00208	CbGpPWpGaD
Amlexanox—FGF1—Disease—CST3—age related macular degeneration	0.00112	0.00205	CbGpPWpGaD
Amlexanox—S100A12—Immune System—C3—age related macular degeneration	0.0011	0.00201	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD36—age related macular degeneration	0.0011	0.002	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—C3—age related macular degeneration	0.00108	0.00197	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—C3—age related macular degeneration	0.00106	0.00194	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CRP—age related macular degeneration	0.00105	0.00191	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—C3—age related macular degeneration	0.00104	0.00189	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CRP—age related macular degeneration	0.00103	0.00188	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFBR1—age related macular degeneration	0.00101	0.00184	CbGpPWpGaD
Amlexanox—S100A12—Immune System—TLR4—age related macular degeneration	0.001	0.00183	CbGpPWpGaD
Amlexanox—FGF1—Immune System—SQSTM1—age related macular degeneration	0.000991	0.00181	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000989	0.0018	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—TLR4—age related macular degeneration	0.000986	0.0018	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—C3—age related macular degeneration	0.000964	0.00176	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—C3—age related macular degeneration	0.000924	0.00169	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000896	0.00164	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—C3—age related macular degeneration	0.000889	0.00162	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—C3—age related macular degeneration	0.00088	0.0016	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFBR1—age related macular degeneration	0.000861	0.00157	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—C3—age related macular degeneration	0.000839	0.00153	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—APOE—age related macular degeneration	0.000827	0.00151	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000819	0.00149	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—C3—age related macular degeneration	0.000814	0.00148	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—KDR—age related macular degeneration	0.000811	0.00148	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—C3—age related macular degeneration	0.000799	0.00146	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SQSTM1—age related macular degeneration	0.00078	0.00142	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000758	0.00138	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCL2—age related macular degeneration	0.000754	0.00138	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000743	0.00135	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—C3—age related macular degeneration	0.000739	0.00135	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000707	0.00129	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCL2—age related macular degeneration	0.000695	0.00127	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000687	0.00125	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD36—age related macular degeneration	0.000664	0.00121	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL2—age related macular degeneration	0.000657	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000641	0.00117	CbGpPWpGaD
Amlexanox—FGF1—Immune System—C3—age related macular degeneration	0.00063	0.00115	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL2—age related macular degeneration	0.000625	0.00114	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CRP—age related macular degeneration	0.000599	0.00109	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL2—age related macular degeneration	0.000578	0.00106	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TLR4—age related macular degeneration	0.000574	0.00105	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—C3—age related macular degeneration	0.000569	0.00104	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOE—age related macular degeneration	0.000541	0.000987	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOE—age related macular degeneration	0.00053	0.000967	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KDR—age related macular degeneration	0.000519	0.000947	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—C3—age related macular degeneration	0.000496	0.000904	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—C3—age related macular degeneration	0.000472	0.000861	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOE—age related macular degeneration	0.000461	0.000842	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KDR—age related macular degeneration	0.000452	0.000825	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—age related macular degeneration	0.000447	0.000815	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL2—age related macular degeneration	0.000446	0.000813	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOE—age related macular degeneration	0.000439	0.000801	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—C3—age related macular degeneration	0.000437	0.000796	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KDR—age related macular degeneration	0.00043	0.000785	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—C3—age related macular degeneration	0.000407	0.000743	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOE—age related macular degeneration	0.000406	0.000741	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KDR—age related macular degeneration	0.000398	0.000726	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL2—age related macular degeneration	0.000388	0.000708	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOE—age related macular degeneration	0.000379	0.000691	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KDR—age related macular degeneration	0.000371	0.000677	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL2—age related macular degeneration	0.000369	0.000674	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL2—age related macular degeneration	0.000342	0.000623	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL2—age related macular degeneration	0.000319	0.000581	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—age related macular degeneration	0.000286	0.000522	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—age related macular degeneration	0.000249	0.000454	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—age related macular degeneration	0.000237	0.000433	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—age related macular degeneration	0.000219	0.0004	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—age related macular degeneration	0.000205	0.000373	CbGpPWpGaD
